Afghanistan's narcotics problems grow worse

By R. Jeffrey Smith and Mattie Quinn

A costly and ambitious U.S. effort to curtail Afghanistan's poppy production falters as U.S. forces draw down.

OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Panel recommends new agency to investigate safety of health information technology

By Kimberly Leonard

Institute of Medicine panel recommends new regulatory body, not FDA

Excerpts from this story referencing "health information technology":

"… to ensure patient safety when doctors and other health care providers use health information technology, or health IT. The findings from the report were presented October 28 to t …"

Overmedicating young Louisiana inmates

By Matt Davis

Incarcerated youths in Louisiana are receiving powerful drugs even when their conditions don't call for it

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

Feds have done little to contain genetically modified animals and plants

By Laurel Adams

Government has done little to ensure genetically modified animals and plants don't escape into wild

Excerpts from this story referencing "investigator":

"… rit the inserted genetic material, but FDA could not confirm this. The FDA investigator said that under the terms of the study protocols, the animals involved in …"

$1 billion for anti-narco programs, and no central database to track it

By Laurel Adams

State Department doesn't have a central tracking mechanism for its $1 billion counter-narcotics programs

Excerpts from this story referencing "Peru":

"… f State’s $1 billion supports programs in Mexico, Afghanistan, Colombia, Peru and Bolivia. The Bureau of International Narcotics and Law Enforcement Aff …"

"… ombia, $281 million to Afghanistan, $249 million to Mexico, $69 million to Peru and $39 million to Bolivia for State’s counter-narcotics efforts. …"

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

Excerpts from this story referencing "Food and Drug Administration":

"… cause cancer, allergic reactions and antibiotic resistance in humans. The Food and Drug Administration is responsible for screening imported seafood, but it may be missing red f …"

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Excerpts from this story referencing "Delaware":

"… ugh, they say it’s difficult to know which is which.Sen. Tom Carper, the Delaware Democrat who requested the OIG investigation, was troubled by the results. …"

Medicare patients received expired, terminated drugs

By Joe Eaton

Medicare patients in 2006-07 likely received more than $112 million worth of expired prescription drugs or drugs that have been pulled from

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Senator seeks deadline for Medicare to prevent prescription drug fraud

By Joe Eaton

Taxpayer-funded Medicare recently spent more than $1 billion on drug prescriptions missing a valid doctor identification number and a Senate

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

Excerpts from this story referencing "Sunlight Foundation":

"… ls.gov, when their products fail to make it to the market,” reported the Sunlight Foundation in 2009.Dr. David Gorski, a surgeon at the Barbara Ann Karmanos Cancer Ins …"

"… he Data Mine is a joint project of the Center for Public Integrity and the Sunlight Foundation. …"

FDA asks hospitals to report safety glitches in digital health systems

By Fred Schulte and Emma Schwartz

In letter to 350 health centers, agency signals growing concern

Excerpts from this story referencing "Jeffrey Shuren":

"… s have not done so.During a hearing in Washington on Feb. 25, FDA official Jeffrey Shuren noted that “several serious safety concerns have come to light.” He sa …"

FDA considers regulating safety of electronic health systems

By Fred Schulte and Emma Schwartz

Reports of patient harm include six deaths in two years

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

Major gaps in oversight of human medical research

By Jeanne Lenzer and Shannon Brownlee

Columbia Hospital case a cautionary tale

Excerpts from this story referencing "Investigative Fund":

"… them of the facts of the study and their surgeries, as the Huffington Post Investigative Fund reported exclusively earlier this month. The hospital has acknow …"

"… Koski, a former head of the Office of Human Research Protections, told the Investigative Fund that he believes it is impossible to know if institutional review boards f …"

"… sold without the warning about heart surgery.An Abbott spokesman told the Investigative Fund that the company has no record of how it obtained the data from the Columb …"

Government orders Columbia to tell patients 'true nature' of drug study

By Jeanne Lenzer and Shannon Brownlee

Officials say research may have caused harm to people who had heart surgery

Excerpts from this story referencing "Abbott Laboratories":

"… trial was to test whether a new formulation of hetastarch, manufactured by Abbott Laboratories, was less likely to trigger serious bleeding at high doses than the other …"

"… d suffering.”An Unrestricted GrantThe Columbia study came at a time when Abbott Laboratories, the manufacturer of one of the blood expanders, was looking to boost its …"

"… received approximately $150,000 in the form of an unrestricted grant from Abbott Laboratories as reimbursement for the comparative study of blood expanders, according t …"

ATF’s ‘ad hoc’ efforts give tobacco smugglers a free pass

By Te-Ping Chen

Smuggling cigarettes in America has become a multi-billion-dollar business, robbing states of desperately needed tax money and fueling organ

Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Excerpts from this story referencing "University of Pennsylvania":

"… X-2s. Dr. Garret FitzGerald, professor of medicine and pharmacology at the University of Pennsylvania, and a consultant to the advisory panel, told the Center, “To lump all p …"

"… ting than science. “This trial is crucial to Celebrex sales,” says the University of Pennsylvania’s FitzGerald. PRECISION is a “post-marketing trial,” a study that is …"

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Excerpts from this story referencing "federal judge":

"… n in November, the Justice Department — representing the FDA — asked a federal judge to permanently enjoin Actavis and Actavis Totowa from manufacturing a vari …"

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Excerpts from this story referencing "drug maker":

"… Ginley contributed to this story. …"

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

Problems in oversight of food safety

By The Center for Public Integrity

Food safety oversight agencies often inconsistent and ineffective, says GAO

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

The expert: watch an interview with Luk Joossens

By ICIJ

Watch an interview with Luk Joossens

Excerpts from this story referencing "Tobacco":

"… experts advising the World Health Organization’s Framework Convention on Tobacco Control — a global treaty to reduce Tobacco use — on how to crack down …"

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

Excerpts from this story referencing "pharmaceutical industry":

"… ashington’s largest lobby. In 2007, as the Center recently reported, the pharmaceutical industry — along with makers of medical devices and other health products — spe …"

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Excerpts from this story referencing "Center for Public Integrity":

"… l in 2007, backed by a record $168 million lobbying effort, according to a Center for Public Integrity analysis of federal lobbying data. Among the industry's successes: getting …"

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

Pages